CB Scientific, Inc. Concludes its Special Meeting of Stockholders

Commanding shareholder approval better positions management to attain enterprise business objectives going forward.

CB Scientific, Inc. to Convene a Special Meeting of Stockholders on Friday, January 14, 2022

Agenda includes transformational matters affecting the Company’s position to manage impending growth

Entered Beta-testing Phase for Updated Proprietary My-Cam Cardiac Event Monitor

Updates to provide device improvements while maintaining the innovative core-functionality of CBSC’s state of the art cardiac event monitor.

Executed Manufacturing Letter of Intent with Shenzhen Pump Medical System Co., Ltd.

Partnership to provide high-volume manufacturing capability and facilitate obtaining requisite government approvals.

Announcing Intent to Convene a Special Meeting of the Stockholders

Agenda to include matters necessary to better position the company for anticipated growth and development.

Application Filed to Uplist to the OTCQB Venture Market

Upgraded listing would provide increased transparency and enhanced trading efficiency.

Announcing The Addition of Brooke Martellaro as Chief Financial Officer

Seasoned finance executive and business leader to add significant incremental competencies to the Company’s executive management team.

Paul Danner Appointed As Chairman

The addition marks the first in a series of executive leadership enhancements intended to position CBSC for accelerated success.

Announcing the Engagement of MaloneBailey, LLP

CB Scientific, Inc (CBSC) begins independent financial audit through MaloneBailey LLP

Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand

Mango Wellness and MyCardia Thailand to begin new remote cardiac monitoring service through pharmacies and clinics in the greater Bangkok market.

  • 1
  • 2

How can we help you?

Tell us what you are interested in.

Get our news in your inbox!

Join our newsletter and we will send our news directly to you.